Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 3
A Phase 3, Randomized, Double-Blind, 48-Week Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of DYNE-101 Administered to Participants With Myotonic Dystrophy Type 1
The purpose of the study is to assess the efficacy, safety, and tolerability of zeleciment basivarsen (DYNE-101) for the treatment of myotonic dystrophy 1 (DM1…
Myotonic Dystrophy Type 1 (DM1)DM1Myotonic Dystrophy+2 more
Dyne TherapeuticsNCT07486934
Myotonic Dystrophy Family Registry
The Myotonic Dystrophy Family Registry (MDFR) is an online, patient-entered database that collects information on myotonic dystrophy (DM) to aid researchers in…
Myotonic DystrophyCongenital Myotonic DystrophyMyotonic Dystrophy 1+13 more
Myotonic Dystrophy FoundationNCT02398786